What question did this study set out to answer?

The aim is to investigate how fucoidan influences kidney fibrosis through gut microbiota alteration and tryptophan metabolism.

April 18, 2026

Fucoidan Alleviates Kidney Fibrosis by Shaping the Gut Microbiota and Modulating Tryptophan Metabolism

Key Points

The aim is to investigate how fucoidan influences kidney fibrosis through gut microbiota alteration and tryptophan metabolism.
Utilized animal models of chronic kidney disease
Administered fucoidan to measure effects on renal fibrosis
Analyzed changes in gut microbiota composition
Evaluated tryptophan metabolic pathways
Fucoidan significantly reduced kidney fibrosis markers
Altered gut microbiota profile favorably
Enhanced tryptophan metabolism pathways related to kidney health

Abstract

Chronic kidney disease (CKD) is a major global health burden, with renal fibrosis as the key pathological driver of disease progression. Fucoidan (FPS) is a sulfated polysaccharide from brown algae...

Bookmark

Cite This Study

Zhang et al. (Thu,) studied this question.

synapsesocial.com/papers/69e3216540886becb6540aec https://doi.org/https://doi.org/10.1039/d6fo00785f

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Bookmark